AMN Healthcare Services (NYSE:AMN) Issues Earnings Results, Beats Estimates By $0.93 EPS

Key Points

• AMN beat third-quarter estimates: EPS was $1.16 versus the $0.23 consensus, while revenue reached $717.3 million, up 13% year over year and above expectations.
• Staffing demand improved, but reported margins got a one-time boost: Nurse and Allied revenue rose 15% excluding labor-disruption activity, while a favorable $51 million reserve adjustment materially lifted gross margin.
• Fourth-quarter revenue guidance exceeded consensus, though headwinds remain: AMN forecast revenue of $655 million–$670 million, but expects lower labor-disruption revenue and visa delays to weigh on international nurse placements.

AMN Healthcare Services (NYSE:AMN - Get Free Report) released its quarterly earnings data on Thursday. The company reported $1.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.93, FiscalAI reports. The business had revenue of $717.27 million during the quarter, compared to analyst estimates of $649.55 million. AMN Healthcare Services had a return on equity of 19.92% and a net margin of 3.06%. The business's revenue for the quarter was up 13.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.39 EPS.

Here are the key takeaways from AMN Healthcare Services' conference call:

• AMN reported third-quarter revenue of $717 million, up 13% year over year, though growth was 6% excluding labor disruption activity. A favorable $51 million reserve adjustment materially boosted reported gross margin; adjusted EBITDA was $94 million.
• Nurse and Allied revenue grew 15% year over year excluding labor disruption activity, with travel nurse volume up 21% and allied volume up 12%. Management attributed the gains to stronger market demand and improved recruiting and placement execution, while noting that bill rates have yet to rise broadly.
• AMN forecast fourth-quarter revenue of $655 million–$670 million and adjusted EBITDA margin of 5.8%–6.3%; the year-over-year revenue decline largely reflects lower labor disruption revenue. Visa appointment delays are also expected to constrain international nurse placements into 2027, with a further sequential step-down anticipated after Q4.
• Technology and Workforce Solutions revenue fell 9% year over year, with language-services pricing down 9% and margin pressured by contract repricing. Management expects its lower-cost global interpreter model to support margin recovery in 2027; it also expects locums process and technology improvements to help return that business to growth next year.

AMN Healthcare Services Stock Down 24.6%

Shares of AMN Healthcare Services stock traded down $11.67 during midday trading on Friday, reaching $35.75. 1,855,562 shares of the company's stock traded hands, compared to its average volume of 948,680. AMN Healthcare Services has a 52 week low of $14.97 and a 52 week high of $49.62. The company's 50 day simple moving average is $38.19 and its 200 day simple moving average is $29.07. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.13 and a current ratio of 1.13. The company has a market cap of $1.38 billion, a price-to-earnings ratio of 13.15, a price-to-earnings-growth ratio of 1.57 and a beta of 0.42.

Key Stories Impacting AMN Healthcare Services

Here are the key news stories impacting AMN Healthcare Services this week:

• Positive Sentiment: Q3 results beat estimates: Adjusted EPS was $1.16 versus consensus of about $0.23, and revenue of $717.3 million exceeded the $649.6 million estimate. Revenue rose 13% year over year. AMN Healthcare Q3 results
• Positive Sentiment: Revenue guidance topped consensus: AMN forecast fourth-quarter 2026 revenue of $655 million–$670 million, above analysts’ $651.7 million estimate. Q3 results and outlook
• Positive Sentiment: Analyst turned more bullish: Citizens JMP raised its AMN price target from $40 to $51 and maintained a “market outperform” rating. Citizens JMP rating

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Wall Street Zen lowered shares of AMN Healthcare Services from a "buy" rating to a "hold" rating in a research note on Tuesday, August 25th. Citigroup reissued an "outperform" rating on shares of AMN Healthcare Services in a report on Friday, August 14th. Truist Financial upped their price objective on shares of AMN Healthcare Services from $26.00 to $40.00 and gave the stock a "buy" rating in a report on Wednesday, July 22nd. UBS Group boosted their price target on shares of AMN Healthcare Services from $32.00 to $35.00 and gave the stock a "neutral" rating in a research report on Friday, August 7th. Finally, Bank of America restated an "underperform" rating on shares of AMN Healthcare Services in a report on Friday. Four research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, AMN Healthcare Services has an average rating of "Hold" and an average target price of $38.33.

About AMN Healthcare Services

AMN Healthcare Services, Inc is a healthcare workforce solutions and technology company that helps hospitals, health systems, medical practices and other healthcare organizations recruit, deploy and manage clinical and nonclinical personnel. The company operates through a portfolio of staffing, workforce management and language-services businesses.

Its services include temporary and permanent placement of registered nurses, allied healthcare professionals and physicians, as well as locum tenens staffing for doctors and advanced practice professionals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.